Advances in targeted and immunobased therapies for colorectal cancer in the genomic era

QR Code

Advances in targeted and immunobased therapies for colorectal cancer in the genomic era

Targeted therapies require information on specific defective signaling pathways or mutations. Advances in genomic technologies and cell biology have led to identification of new therapeutic targets associated with signal-transduction pathways. Survival times of patients with colorectal cancer (CRC)...

Full description

Bibliographic Details
Main Authors:	Heng, Fong Seow, Wai, Kien Yip, Fifis, Theodora
Format:	Article
Language:	English
Published:	Dove Medical Press 2016
Online Access:	http://psasir.upm.edu.my/id/eprint/54981/ http://psasir.upm.edu.my/id/eprint/54981/1/Advances%20in%20targeted%20and%20immunobased%20therapies.pdf

Similar Items

Identifying common mutations in colorectal cancer using a 7-gene panel by next generation sequencing
by: Chai, Boon Lee, et al.
Published: (2019)

Loss of interleukin17RA expression is associated with tumour progression in colorectal carcinoma
by: Chai, Boon Yean, et al.
Published: (2020)

COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer
by: Ryan, A R, et al.
Published: (1999)

Identification of drug(s) selectively targeting colorectal cancer stem-like cells for differentiation (differentiation therapy)
by: Ahmed, Mehreen
Published: (2020)

Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous E-cadherin and â-catenin and enhances invasion in nasopharyngeal carcinoma cells.
by: Wai, Kien Yip, et al.
Published: (2012)

Radionuclide targeted therapy, theranostics, and precision medicine in the era of hybrid imaging: an important pillar in cancer care
by: Suppiah, Subapriya, et al.
Published: (2022)

Differential effects of dishevelled 2 and 3 on TCF/ LEF- mediated transcriptional activation in wnt-3atreated breast cancer cell line MDA-MB-231
by: Khoo, Samuel Leon Juan, et al.
Published: (2017)

Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia
by: Yip, Wai Kien, et al.
Published: (2013)

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: Study design
by: Rigter, L., et al.
Published: (2017)

Prediction of colorectal cancer driver genes from patients’ genome data
by: Muhammad-Iqmal Abdullah,, et al.
Published: (2018)

Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer
by: Ko, S., et al.
Published: (2014)

Wnt Signaling Regulation of Tissue Architecture (EMT and MET) and Morphogenesis: Consequences for Colorectal and Liver Cancer
by: Fifis, T., et al.
Published: (2014)

Inhibition of cell migration and invasion by miR-29a-3p in a colorectal cancer cell line through suppression of CDC42BPA mRNA expression
by: He, Pei Yuan, et al.
Published: (2017)

Integrating personalised genomics into risk stratification models of population screening for colorectal cancer
by: Cenin, Dayna, et al.
Published: (2017)

Molecular targets of colorectal cancer: an insight on intracellular cellular signaling pathways
by: Pandurangan, Ashok Kumar, et al.
Published: (2014)

Dietary non-nutritive factors on molecular targets of colorectal cancer: an update
by: Pandurangan, Ashok Kumar, et al.
Published: (2013)

5-Fluorouracil induce the expression of TLR4 on HCT116 colorectal cancer cell line expressing different variants of TLR4
by: Davoodi, Homa, et al.
Published: (2013)

Cancer-associated membrane protein as targeted therapy for bladder cancer
by: Roslan, Adlina, et al.
Published: (2022)

Current update of laboratory molecular diagnostics advancement in management of colorectal cancer (CRC)
by: Pang, Siew Wai *, et al.
Published: (2019)

Variant toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and toll-like receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer.
by: Davoodi, H., et al.
Published: (2011)

Biomarkers in cancer: an overview
by: Seow, Heng Fong
Published: (2008)

Cost-Effectiveness of an Advance Notification Letter to Increase Colorectal Cancer Screening
by: Cronin, P., et al.
Published: (2013)

Cancer stem cell metabolism: A potential target for cancer therapy
by: Deshmukh, A., et al.
Published: (2016)

DNA repair in cancer: emerging targets for personalized therapy
by: Abbotts, Rachel, et al.
Published: (2014)

Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
by: Min-Wen, J., et al.
Published: (2017)

Towards targeted cancer therapy: Aptamer or oncolytic virus?
by: Tan, K., et al.
Published: (2017)

Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022)

Isolation and identification of long non-coding RNAs in exosomes derived from the serum of colorectal carcinoma patients
by: Ng, Chin Tat, et al.
Published: (2021)

Advancing the clinical implementation of Clostridial cancer therapies
by: Zygouropoulou, Maria
Published: (2019)

Are there “Magic Bullets” for cancer theraphy
by: Seow, Heng Fong
Published: (2011)

Elucidation of mRNA targets of miR-145-5p in diabetic kidney disease using bioinformatics analysis
by: Zahari Sham, Siti Yazmin, et al.
Published: (2022)

Characterisation of tumorspheres generated from nasopharyngeal carcinoma cell line TW06 and chemoresistance to docetaxel
by: Goh, Iris Wen Li, et al.
Published: (2015)

Characterization of tumorspheres generated from nasopharyngeal carcinoma cell line, TW06 and chemoresistance to docetaxel and oxaliplatin
by: Goh, Iris Wen Li, et al.
Published: (2015)

Immunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors α and β in Malaysian breast cancer patients
by: Seow, Heng Fong, et al.
Published: (2010)

Colorectal cancer stem cells: a review of targeted drug delivery by gold nanoparticles
by: Mohd Zahid, Manali Haniti, et al.
Published: (2020)

Detection of epstein - barr virus (EBV) in nasopharyngeal cancer.
by: Seow, Heng Fong
Published: (2007)

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

Prediction of mRNA targets of miR-101-3p in diabetic kidney disease by bioinformatics tools
by: Zahari Sham, Siti Yazmin, et al.
Published: (2022)

Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.
by: Seow, Heng Fong, et al.
Published: (2009)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)